Protalix BioTherapeutics
PLX
#8261
Rank
C$0.31 B
Marketcap
C$3.93
Share price
-0.34%
Change (1 day)
20.50%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02720. In 2024 the company made an earnings per share (EPS) of C$0.05440 a decrease over its 2023 EPS that were of C$0.16.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-56.02%
2024C$0.05440-66.67%
2023C$0.16-138.71%
2022C-$0.42-50%
2021C-$0.84181.82%
2020C-$0.30-82.11%
2019C-$1.67-31.67%
2018C-$2.45-72.31%
2017C-$8.84124.14%
2016C-$3.94-147.54%
2015C$8.30-290.63%
2014C-$4.356.67%
2013C-$4.08130.77%
2012C-$1.77-69.77%
2011C-$5.8519.44%
2010C-$4.90-12.2%
2009C-$5.5836.67%
2008C-$4.08-37.5%
2007C-$6.5350%
2006C-$4.353.23%
2005C-$4.22138.46%
2004C-$1.77-74%
2003C-$6.80-0%
2002C-$6.80-50%
2001C-$13.60233.33%
2000C-$4.08-84.21%
1999C-$25.84-24%
1998C-$34.00-600%
1997C$6.80-16.67%
1996C$8.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$5.86 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.69 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel